Insider · CIK 0001563584

LEONARD JOHN M

Reports to the SEC for 5 companies · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001563584

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-21	NTLAIntellia Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−2,785 sh	$13.00	−$36.2K	1,147,064
2026-08-20	NTLAIntellia Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−19.9K sh	$12.60	−$251K	1,149,849
2026-04-23	IQVIQVIA HOLDINGS INC.A Award	Director	AAward	+1,571 sh	—	—	16,946
2026-03-01	NTLAIntellia Therapeutics, Inc.A Award	Director, President and CEO	AAward	+156K sh	—	—	1,169,739
2026-03-01	NTLAIntellia Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, President and CEO	AAward	+225K sh	—	—	225,400
2026-01-05	NTLAIntellia Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−34.1K sh	$9.21	−$314K	1,013,339
2025-12-12	NTLAIntellia Therapeutics, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+8,557 sh	$6.83	+$58.4K	1,047,485
2025-12-12	NTLAIntellia Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−8,557 sh	—	—	0
2025-12-11	NTLAIntellia Therapeutics, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+50K sh	$6.83	+$341K	1,127,074
2025-12-11	NTLAIntellia Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−50K sh	$9.49	−$474K	1,077,115
2025-12-11	NTLAIntellia Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−32.8K sh	$9.47	−$311K	1,044,283
2025-12-11	NTLAIntellia Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−5,355 sh	$9.59	−$51.4K	1,038,928
2025-12-11	NTLAIntellia Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−50K sh	—	—	8,557
2025-04-24	IQVIQVIA HOLDINGS INC.A Award	Director	AAward	+1,592 sh	—	—	15,375
2025-03-01	NTLAIntellia Therapeutics, Inc.A Award	Director, President and CEO	AAward	+136K sh	—	—	1,077,115
2025-03-01	NTLAIntellia Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, President and CEO	AAward	+196K sh	—	—	196,000
2025-01-03	NTLAIntellia Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−26.8K sh	$12.18	−$327K	941,115
2025-01-01	NTLAIntellia Therapeutics, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+7,850 sh	—	—	967,922
2025-01-01	NTLAIntellia Therapeutics, Inc. · Restricted Stock UnitM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−7,850 sh	—	—	0
2024-05-07	IQVIQVIA HOLDINGS INC.A Award	Director	AAward	+1,047 sh	—	—	13,783
2024-03-01	NTLAIntellia Therapeutics, Inc.A Award	Director, President and CEO	AAward	+114K sh	—	—	960,072
2024-03-01	NTLAIntellia Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, President and CEO	AAward	+164K sh	—	—	163,929
2024-01-03	NTLAIntellia Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−19.2K sh	$29.46	−$566K	846,486
2024-01-01	NTLAIntellia Therapeutics, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+7,848 sh	—	—	865,709
2024-01-01	NTLAIntellia Therapeutics, Inc. · Restricted Stock UnitM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−7,848 sh	—	—	7,850
2023-05-10	IQVIQVIA HOLDINGS INC.A Award	Director	AAward	+1,063 sh	—	—	12,736
2023-03-01	NTLAIntellia Therapeutics, Inc.A Award	Director, President and CEO	AAward	+91K sh	—	—	857,861
2023-03-01	NTLAIntellia Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, President and CEO	AAward	+129K sh	—	—	128,631
2023-01-04	NTLAIntellia Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−6,673 sh	$37.21	−$248K	766,825
2023-01-01	NTLAIntellia Therapeutics, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+7,848 sh	—	—	773,498
2023-01-01	NTLAIntellia Therapeutics, Inc. · Restricted Stock UnitM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−7,848 sh	—	—	15,698
2022-05-11	IQVIQVIA HOLDINGS INC.A Award	Director	AAward	+995 sh	—	—	11,673
2022-03-01	NTLAIntellia Therapeutics, Inc.A Award	Director, President and CEO	AAward	+41K sh	—	—	765,650
2022-03-01	NTLAIntellia Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, President and CEO	AAward	+59.9K sh	—	—	59,941
2022-01-01	NTLAIntellia Therapeutics, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+7,848 sh	—	—	727,153
2022-01-01	NTLAIntellia Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−2,493 sh	$112.25	−$280K	724,660
2022-01-01	NTLAIntellia Therapeutics, Inc. · Restricted Stock UnitM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−7,848 sh	—	—	23,546
2021-09-01	NTLAIntellia Therapeutics, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+28.8K sh	$23.46	+$674K	748,055
2021-09-01	NTLAIntellia Therapeutics, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+16K sh	$18.30	+$293K	764,040
2021-09-01	NTLAIntellia Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−44.7K sh	$170.00	−$7.6M	719,305
2021-09-01	NTLAIntellia Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−28.8K sh	—	—	0
2021-09-01	NTLAIntellia Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−16K sh	—	—	11,515
2021-08-31	NTLAIntellia Therapeutics, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+37.8K sh	$14.58	+$552K	757,138
2021-08-31	NTLAIntellia Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−37.8K sh	$155.00	−$5.86M	719,305
2021-08-31	NTLAIntellia Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−37.8K sh	—	—	90,000
2021-08-30	NTLAIntellia Therapeutics, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+11.6K sh	$13.40	+$156K	730,942
2021-08-30	NTLAIntellia Therapeutics, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+27.2K sh	$14.58	+$396K	758,109
2021-08-30	NTLAIntellia Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−2,055 sh	$152.81	−$314K	756,054
2021-08-30	NTLAIntellia Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−2,334 sh	$153.66	−$359K	753,720
2021-08-30	NTLAIntellia Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−7,428 sh	$154.98	−$1.15M	746,292

Recent filings

Accepted (ET)
Aug 244
LEONARD JOHN M0001193125-26-363567
SEC(opens sec.gov)
Apr 274
LEONARD JOHN M0001628280-26-027609
SEC(opens sec.gov)
Mar 34
LEONARD JOHN M0001193125-26-088269
SEC(opens sec.gov)
Jan 74
LEONARD JOHN M0001193125-26-006294
SEC(opens sec.gov)
Dec 124
LEONARD JOHN M0001193125-25-317551
SEC(opens sec.gov)
Apr 254
LEONARD JOHN M0001478242-25-000072
SEC(opens sec.gov)
Mar 44
LEONARD JOHN M0000950170-25-032248
SEC(opens sec.gov)
Jan 74
LEONARD JOHN M0000950170-25-003012
SEC(opens sec.gov)
Jan 34
LEONARD JOHN M0000950170-25-001236
SEC(opens sec.gov)
May 94
LEONARD JOHN M0001478242-24-000079
SEC(opens sec.gov)

Companies

Address

C/O INTELLIA THERAPEUTICS, INC. 40 ERIE STREET; SUITE 130

CAMBRIDGE, MA, 02139